CMS also expanded the program to include joint replacements performed in the hospital outpatient department in a final rule published April 29. The estimated net savings for lower extremity joint replacements in the first three years of the program reached $61.6 million, driven by lower use of post-acute care.
The agency revealed plans to update the target price calculation in the final rule. Going forward, CMS will consider the last year of claims data as the basis for the target price, instead of considering three years of claims data.
Click here to read more about the final rule.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
